XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Total revenues $ 6,825 $ 1,704
Cost of revenues (exclusive of depreciation and amortization shown separately below) 6,687 960
Operating expenses    
Research and development 5,819 5,075
General and administrative 10,005 7,656
Depreciation and amortization 2,311 288
Total operating expenses 18,135 13,019
Loss from operations (17,997) (12,275)
Other income (expenses)    
Interest income 1,864 3,014
Interest expense (117) 0
Gain in fair value of derivatives 296 760
Gain in fair value of common stock warrants liability 649 6,766
Gain in fair value of earnout liability 1,518 12,872
Other expenses, net (8) (1,368)
Total other income, net 4,202 22,044
(Loss) income before income tax expenses (13,795) 9,769
Income tax expenses (118) 0
Net (loss) income (13,913) 9,769
Other comprehensive (loss) income    
Unrealized gain on marketable securities 570 1,410
Foreign currency translation adjustment (3,844) 120
Total other comprehensive (loss) income (3,274) 1,530
Total comprehensive (loss) income $ (17,187) $ 11,299
Net (loss) income per share, basic (in dollars per share) $ (0.10) $ 0.07
Net (loss) income per share, diluted (in dollars per share) $ (0.10) $ 0.07
Weighted-average common shares outstanding, basic (in shares) 141,828,895 138,651,062
Weighted-average common shares outstanding, diluted (in shares) 141,828,895 142,454,369
Products    
Revenues:    
Total revenues $ 6,822 $ 979
Services    
Revenues:    
Total revenues $ 3 $ 725